Cointime

  • News
  • Insight
  • Currencies
  • Columns
  • Events
  • Bitcoin $114,984.93 -0.17%
  • Ethereum $4,139.31 -0.55%
  • BNB $1,144.91 -2.29%
  • Optimism $0.46 +0.61%
  • Arbitrum $0.33 -0.46%
  • Solana $202.18 +0.99%
  • Polygon $0.22 +2.77%
  • Cosmos $3.20 -0.04%
  • Avalanche $20.39 -0.46%
  • Bitcoin $114,984.93 -0.17%
  • Ethereum $4,139.31 -0.55%
  • BNB $1,144.91 -2.29%
  • Optimism $0.46 +0.61%
  • Arbitrum $0.33 -0.46%
  • Solana $202.18 +0.99%
  • Polygon $0.22 +2.77%
  • Cosmos $3.20 -0.04%
  • Avalanche $20.39 -0.46%
Home / EpimAb Biotherapeutics / investors

EpimAb Biotherapeutics

company

Investors

Number of Lead Investors
Number of Investors
5
16
EpimAb Biotherapeutics is funded by 16 investors. MiraeAsset Financial Group and CMB International Capital Corporation are the most recent investors.
Investor Name Lead Investor Funding Round
MiraeAsset Financial Group Yes Series C
CMB International Capital Corporation Yes Series C
Oriza Seed Capital (Oriza Yuandian) Yes Series A
Hidragon Capital - Series C
Adrian Cheng - Series C
Cormorant Asset Management - Series C
Decheng Capital - Series C
Hony Capital - Series C
Octagon Capital Advisors - Series C
SDIC Fund Management - Series C
Shangbay Capital - Series C
Sherpa Venture Capital - Series C
Yanchuang Capital - Series C
South China Venture Capital - Series B
3E Bioventures - Series A
Trend Investment Group - Series A

Contact

Shanghai,Shanghai,China
+49 (0) 15226107621
Cointime
Insight
  • Latest News
  • Web3
  • Blockchain
  • Metaverse
  • Bitcoin
  • Ethereum
  • NFT
  • DeFi
Features
  • Startups
  • Research
  • Technology
  • Topics
  • Columns
  • Currencies
  • Events
  • Tags
RSS
  • Latest News
  • Startups
  • Research
  • Technology
Company
  • About
  • Advertise
  • Disclaimers
  • © 2023 Cointime. All rights reserved.
  • Privacy Policy
  • Terms & Conditions